Charts

CASI Pharmaceuticals, Inc. (NASDAQ: CASI) ("CASI" or the "Company"), a biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced that the redomiciliation merger to redomicile the Company as a Cayman Islands company (the "Redomiciliation Merger") has been completed.

Looking at CASI Pharmaceuticals, Inc.'s ( NASDAQ:CASI ) insider transactions over the last year, we can see that...

MARKET PULSE Shares of Casi Pharmaceuticals Inc. (CASI) were up 10% in premarket trading on Friday after the company said China will allow a Phase 1 clinical trial evaluating a multiple myeloma drug developed by the privately held Cleave Therapeutics.

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announces that the China National Medical Products Administration (NMPA) has approved the Company's Clinical Trial Application (CTA) for CB-5339, a first-in-class VCP/p97 inhibitor from Cleave Therapeutics. CASI is planning a Phase 1 development program in China of CB-5339 as a single agent to evaluate the PK/safety profile, se

According to data from Benzinga Pro, during Q3, CASI Pharmaceuticals's (NASDAQ:CASI) reported sales totaled $10.21 million. Despite a ...

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announces that China National Medical Products Administration (NMPA) has accepted the new drug application (NDA) from Juventas Cell Therapy, Ltd., (Juventas) for CNCT19 (Inaticabtagene Autoleucel), an investigational CD-19 directed CAR-T therapy, for the treatment of adult patients with relapsed/refractory B-Cell Acute Ly

CASI Pharmaceuticals ( NASDAQ:CASI ) Third Quarter 2022 Results Key Financial Results Revenue: US$10.2m (up 26% from 3Q...

CASI Pharmaceuticals, Inc. (CASI) delivered earnings and revenue surprises of 25.49% and 1.80%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial results for the third quarter of 2022.

Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday. Kiromic BioPharma, ...

Chia Tai-Tianqing Pharma, a subsidiary of Sino Biopharma, in-licensed Greater China rights to a therapy for non-alcoholic steatohepatitis from Inventiva in a $307 million deal. Meanwhile, CASI Pharma sold its 12% stake in its partner for $34 million.

Gainers Kiromic BioPharma (NASDAQ:KRBP) stock rose 71.7% to $0.44 during Friday's regular session. As of 13:30 EST, Kiromic ...

CASI Pharmaceuticals, Inc. (NASDAQ: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products ("CASI"), today announced that CASI Biopharmaceuticals (Wuxi) Co., Ltd, a subsidiary of CASI Pharmaceuticals, Inc. ("CASI Wuxi"), entered into an Equity Transfer Agreement with Shenzhen Jiadao Gongcheng Equity Investment Fund, LLP ("Jiadao Gongcheng"), pursuant to which CASI Wuxi agreed to transfer its equity interest in Juventa

Beijing BoomRay Pharma, a joint venture between WuXi AppTec and Peking University, completed a $43 million Series A funding to develop novel radionuclide drugs that integrate diagnosis and treatment.

The Dow Jones closed higher by around 193 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When ...

According to data from Benzinga Pro, during Q2, CASI Pharmaceuticals's (NASDAQ:CASI) reported sales totaled $8.57 million. Despite a ...

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, and BioInvent International AB ("BioInvent") (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, today announced the first-patient-in in China Phase 1 dose-escalation and expansion study of BI-1206, a first-in-cla

The Dow Jones tumbled by over 1,000 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders ...

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at a noteworthy recent insider buy.

Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter ...

Gainers Artelo Biosciences (NASDAQ:ARTL) stock increased by 46.9% to $6.4 during Tuesday's regular session. Trading ...

CASI Pharmaceuticals, Inc. (CASI) delivered earnings and revenue surprises of 13.85% and 19.70%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

CASI Pharmaceuticals (NASDAQ:CASI) reported its Q2 earnings results on Friday, August 12, 2022 at 07:00 AM. Here's what ...

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial results for the second quarter of 2022.

CASI Pharmaceuticals, Inc. ( NASDAQ:CASI ) shareholders are doubtless heartened to see the share price bounce 58% in...

Companies Reporting Before The Bell • NeoGenomics (NASDAQ:NEO) is projected to report quarterly earnings at $0.44 per ...

Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported ...

Gainers Timber Pharmaceuticals, Inc. (NYSE: TMBR) shares rose 63.8% to $0.1769. Timber Pharmaceuticals recently announced closing ...

CASI Pharmaceuticals (NASDAQ:CASI) is set to give its latest quarterly earnings report on Friday, 2022-08-12. Here's what ...

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced the Company will host a conference call reviewing the financial results for the second quarter of 2022, at 8:00 A.M. EST on Friday, August 12th, 2022.

Gainers Missfresh Limited (NASDAQ: MF) shares rose 112.9% to $0.2450 in pre-market trading after dropping 7% on ...

Gainers Exicure (NASDAQ:XCUR) shares increased by 97.0% to $3.92 during Wednesday's after-market session. This security traded at a ...

New investments in China life science may have declined over the last year, but large investment companies continue to raise large sums to invest. Sequoia China has raised about $9 billion to make investments in China’s healthcare and tech companies.

CASI Pharmaceuticals, Inc. (NASDAQ: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced that Precision Autoimmune Therapeutics Co., Ltd., (PAT), previously known as Beijing Tianshi Tongda Pharmaceuticals Technology Co., Ltd (TIANSHI), has completed the first-round financing which raised RMB140 million (approximately $21 million). After completion of the first-round financing, CASI holds a 15% stake

Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be ...

Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.8% to $10.31 as the company agreed to be taken ...

Gainers Valneva SE(NASDAQ: VALN) shares rose 83.6% to $25.18in pre-market trading following Pfizer agreement to ...

Gainers Travere Therapeutics (NASDAQ:TVTX) stock increased by 16.5% to $28.87 during Friday's after-market session. The market value ...

Gainers NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) shares gained 47.5% to settle at $0.8436 on Thursday. Based on the review of ...

Gainers Repare Therapeutics Inc. (NASDAQ: RPTX) jumped 38.1% to $12.08 after the company announced it has entered into a worldwide ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Chipotle (CMG) stock is on the move Thursday after the fast-food company confirmed that it's now accepting crypto payments. The post Chipotle Is Accepting Flexa Crypto Payments. 10 Things to Know. appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

InvestorPlace - Stock Market News, Stock Advice & Trading Tips CASI Pharmaceuticals (CASI) stock rocketed higher in pre-market trading this morning but it's not due to any positive news from the company. The post Why Is CASI Pharmaceuticals (CASI) Stock Up 700% Today? appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

U.S. stocks traded lower this morning, with the Dow Jones dropping 200 points on Thursday. Following the market opening Thursday, the ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investors! It's time to start another day of trading with the biggest pre-market stock movers for Thursday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

Gainers Missfresh Limited (NASDAQ: MF) jumped 51.1% to close at $0.2450 on Wednesday. Spark Networks SE (NASDAQ: LOV) jumped ...

Gainers Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) shares jumped 63.9% to $3.9990 after the company announced the USPTO ...

Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares ...

Fosun Pharma acquired China rights to a novel broad cancer immunotherapy candidate from VerImmune of Baltimore in an $125 million agreement. Fosun will pay VerImmune up to $125 million in upfront and milestone payments, plus tiered royalties.

Gainers Avadel Pharmaceuticals (NASDAQ:AVDL) stock increased by 32.7% to $1.42 during Friday's pre-market session. ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're starting the final day of trading for the week with a breakdown of the biggest pre-market stock movers for Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

Gainers Creatd, Inc. (NASDAQ: CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd’s board approved a rights ...

Gainers Adicet Bio (NASDAQ:ACET) stock moved upwards by 24.9% to $12.82 during Thursday's after-market session. Trading volume for ...

CASI Pharmaceuticals, Inc. (NASDAQ: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced it has filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation to implement a 1-for-10 reverse stock split that will become effective at 5:00 p.m., Eastern Time, on June 1, 2022. The primary objective of implementing a reverse split is to satisfy the minimum bid price requiremen

Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares gained 46.6% to $0.9824. Healthcare Triangle recently posted a ...

Viewing insider transactions for CASI Pharmaceuticals, Inc.'s ( NASDAQ:CASI ) over the last year, we see that insiders...

CASI Pharmaceuticals, Inc. (NASDAQ: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced the signing of a Sublicense Agreement with Beijing Tianshi Tongda Pharmaceuticals Technology Co., Ltd., ("TIANSHI") a clinical stage pharmaceutical company organized and existing under the laws of the People's Republic of China ("PRC"). The Sublicense Agreement grants TIANSHI an exclusive, perpetual, worldwide l

CASI Pharma, a Maryland-Beijing biopharma, will sublicense global rights to develop its anti-CD38 candidate for autoimmune conditions to Beijing Tianshi Tongda Pharmaceuticals. Tianshi will make a $10 million upfront payment to CASI, while CASI will contribute $3 million to Tianshi’s $21 million venture funding in exchange for a 15% Tianshi stake. Although the agreement is supposed to be global, CASI will book all US revenues from the CD38 for autoimmune indications and (possibly) for hematology-autoimmune indications in China. CASI originally acquired CID-103 as a therapy for multiple myeloma. More details.... Stock Symbol: (NSDQ: CASI) Share this with colleagues:  

Gainers Data Storage Corporation (NASDAQ: DTST) shares jumped 51.1% to $3.4750 after the company reported better-than-expected Q1 ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back and get ready for another busy week of trading as we start it off with the biggest pre-market stock movers for Monday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) rose 25.2% to $2.09 in pre-market trading after gaining around 10% on ...

CASI Pharmaceuticals (NASDAQ:CASI) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need ...

CASI Pharmaceuticals, Inc. (CASI) delivered earnings and revenue surprises of 40% and 0.96%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Q1 2022 CASI Pharmaceuticals Inc Earnings Call

CASI Pharmaceuticals (NASDAQ:CASI) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The SEC has released a massive list of Chinese stocks that could face delisting on Holding Foreign Companies Accountable Act news. The post HFCAA News: 128 Chinese Stocks the SEC Could Delist appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”